Crispr Therapeutics AG (1CG)
Market Closed
12 Jun, 20:00
€
43. 10
+0.3
+0.6893%
€
4.16B Market Cap
- P/E Ratio
- Div Yield
560 Volume
-2.71 Eps
€ 42.8
Previous Close Want to track 1CG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Crispr Therapeutics AG (1CG) Statistics
Valuation metrics
Market Cap 4.16B
Enterprise value 2.33B
Trailing P/E (ttm) -6.36
Forward P/E -
PEG ratio 0.33
Price/Sales (ttm) 1,061.92
Price/Book (mrq) 2.81
Enterprise Value/Revenue 658.77
Enterprise Value/EBITDA -5.09
Overview
Shares outstanding 96.39M
Float 96.04M
Shares short -
% Held by insiders 0.06%
% Held by institutions 0.79%
Average volume (10 days) 170
Average volume (90 days) 208
Price summary
52-Week low 34.4
52-Week high 68.5
Beta 1.74
50-Day moving average 43.76
200-Day moving average 47.72
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 333,333:100,000
Last split Date 19 Jul 2016
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -
Operating margin -89.33%
Operational effectiveness
Return on assets -0.14%
Return on equity -0.31%
Income Statement
Revenue (ttm) 3.53M
Revenue per share (ttm) 0.04
Quarterly revenue growth (yoy) 0.69%
Gross profit (ttm) -411.94M
EBITDA -457M
Net income to common (ttm) -489.23M
Diluted EPS (ttm) -5.27
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 2.1B
Total cash per share (mrq) 25.32
Total debt (mrq) 677.77M
Total Debt/Equity (mrq) 43.41
Current ratio (mrq) 17.96%
Book value per share (mrq) 16.07
Cash Flow
Cash flow statement -344.17M
Levered free cash flow (LFCF) -224.5M
